Mathiéu Molimard

Adherence Is the Critical Factor for Achieving Molecular Responses in Patients With Chronic Myeloid Leukemia Who Achieve Complete Cytogenetic Responses on Imatinib

David Marín, Alexandra Bazeos, François-Xavier Mahon et al. · Journal of Clinical Oncology · 2010 · 890 citations · Full text

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphane Picard, Karine Titier, Gabriel Étienne et al. · Blood · 2006 · 604 citations · Full text

Assessment of Handling of Inhaler Devices in Real Life: An Observational Study in 3811 Patients in Primary Care

Mathiéu Molimard, Chantal Rahérison, S. Lignot et al. · Journal of Aerosol Medicine · 2003 · 391 citations

Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy

Amr R. Ibrahim, Lina Eliasson, Jane F. Apperley et al. · Blood · 2011 · 314 citations · Full text

Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients

Mathiéu Molimard, Chantal Rahérison, S. Lignot et al. · European Respiratory Journal · 2016 · 267 citations · Full text